SKI Market

A+| A| A-|

Indian Indices

Sensex

72,696.39 -1,836.57
( -2.46%)

Global Indices

Nasdaq

45,612.20 -430.24
(-0.93%)

Dow Jones

6,526.68 -100.81
(-1.52%)

Hang Seng

51,583.72 -1,788.81
(-3.35%)

Nikkei 225

9,927.54 -135.96
(-1.35%)

Forex

USD-INR

93.13 0.41
(0.44%)

EUR-INR

107.17 0.41
(0.39%)

GBP-INR

124.14 0.56
(0.45%)

JPY-INR

0.59 0.00
(0.73%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

411.5542386

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

22.14

101445.38

EPS(TTM)

Face Value()

Div & Yield %

56.72

1.27

Back

Cipla consolidated net profit declines 56.97% in the December 2025 quarter

Jan 23,2026

Net profit of Cipla declined 56.97% to Rs 675.80 crore in the quarter ended December 2025 as against Rs 1570.51 crore during the previous quarter ended December 2024. Sales rose 0.02% to Rs 6962.97 crore in the quarter ended December 2025 as against Rs 6961.60 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	6962.97	6961.60	0
OPM %	18.02	28.57	-
PBDT	1447.37	2195.89	-34
PBT	1169.02	1916.09	-39
NP	675.80	1570.51	-57

72,696.39 -1,836.57 ( -2.46%)

45,612.20 -430.24 (-0.93%)

6,526.68 -100.81 (-1.52%)

51,583.72 -1,788.81 (-3.35%)

9,927.54 -135.96 (-1.35%)

93.13 0.41 (0.44%)

107.17 0.41 (0.39%)

124.14 0.56 (0.45%)

0.59 0.00 (0.73%)